{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T20:09:52Z","timestamp":1779480592650,"version":"3.53.1"},"reference-count":55,"publisher":"FapUNIFESP (SciELO)","issue":"2","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["60030000739\/2013"],"award-info":[{"award-number":["60030000739\/2013"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003401","name":"FAPEAL","doi-asserted-by":"crossref","award":["60030000739\/2013"],"award-info":[{"award-number":["60030000739\/2013"]}],"id":[{"id":"10.13039\/501100003401","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100017013","name":"UFAL","doi-asserted-by":"crossref","award":["60030000739\/2013"],"award-info":[{"award-number":["60030000739\/2013"]}],"id":[{"id":"10.13039\/501100017013","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Acad. Bras. Ci\u00eanc."],"abstract":"<jats:p>Abstract Cryptococcosis is a concerning fungal disease caused by encapsulated yeasts of the Cryptococcus neoformans\/C. gattii species complexes, which can spread systemically, leading to meningitis with a high mortality. Treatment of cryptococcosis is a time-consuming process, relies on antifungals of limited distribution, and varies in effectiveness due to differing susceptibility profiles, particularly to azoles. This research aimed to evaluate the antifungal susceptibility of Cryptococcus spp. strains to amphotericin B, ketoconazole, fluconazole, and itraconazole, using clinical strains. Cryptococcus spp. strains were identified through India ink test and urease\/phenoloxidase production, with species differentiation using canavanine-glycine-bromothymol blue (CGB) agar. Minimum inhibitory concentrations (MICs) for the antifungals were determined using the Etest (episometer test). Twelve clinical isolates collected from nine patients at Hospital Escola Dr. H\u00e9lvio Auto in Macei\u00f3, Alagoas, were identified as C. neoformans type VNI. The MIC ranges were amphotericin B (0.023 \u2013 0.25 \u03bcg\/mL); ketoconazole (0.047 \u2013 3 \u03bcg\/mL); fluconazole (1 \u2013 &gt;256 \u03bcg\/mL); and itraconazole (0.032 \u2013 2 \u03bcg\/mL). Notably, some strains exhibited MIC values exceeding the epidemiological cutoff values for fluconazole and itraconazole, indicating a non-wild type (non-WT) phenotype. This study identified C. neoformans VNI strains with reduced azole susceptibility, emphasizing the need for antifungal resistance monitoring to guide treatment strategies.<\/jats:p>","DOI":"10.1590\/0001-3765202620251002","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T20:00:33Z","timestamp":1779480033000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical strains of Cryptococcus neoformans VNI non-wild type for azoles from Macei\u00f3, Alagoas, Brazil"],"prefix":"10.1590","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7265-2133","authenticated-orcid":false,"given":"ARTHUR D.B.R. DE","family":"OLIVEIRA","sequence":"first","affiliation":[{"name":"Universidade Federal de Alagoas,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5856-259X","authenticated-orcid":false,"given":"DOUGLAS L.H.","family":"FONSECA","sequence":"additional","affiliation":[{"name":"National Institutes of Health (NIH),  U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9641-4264","authenticated-orcid":false,"given":"DENISE MARIA W.","family":"SILVA","sequence":"additional","affiliation":[{"name":"Universidade Federal de Alagoas,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4255-6563","authenticated-orcid":false,"given":"FERNANDA CRISTINA A.","family":"MARANH\u00c3O","sequence":"additional","affiliation":[{"name":"Universidade Federal de Alagoas,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2026]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/myc.12499","article-title":"Molecular typing of environmental Cryptococcus neoformans\/C gattii species complex isolates from Manaus, Amazonas, Brazil","volume":"59","author":"ALVES GS","year":"2016","journal-title":"Mycoses"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1007\/s42770-024-01378-y","article-title":"Antifungal susceptibility and multilocus sequence typing (MLST) of Cryptococcus neoformans complex from HIV-associated cryptococcal meningitis patients in Manaus, Amazonas, Brazil","volume":"55","author":"ALVES MJ","year":"2024","journal-title":"Braz J Microbiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3109\/13693786.2012.761737","article-title":"Susceptibility profile of clinical and environmental isolates of Cryptococcus neoformans and Cryptococcus gattii in Uberaba, Minas Gerais, Brazil","volume":"51","author":"ANDRADE-SILVA L","year":"2013","journal-title":"Med Mycol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/myc.13174","article-title":"Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans\/Cryptococcus gattii species complex clinical isolates from south-eastern Brazil","volume":"63","author":"BARI\u00c3O PHG","year":"2020","journal-title":"Mycoses"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.cmi.2020.02.017","article-title":"Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians?","volume":"26","author":"BASSETTI M","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"ref6","first-page":"1","article-title":"What\u2019s New in Cryptococcus gattii: From Bench to Bedside and Beyond","volume":"9","author":"BEARDSLEY J","year":"2023","journal-title":"J Fungi"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s15010-017-1042-z","article-title":"Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients","volume":"45","author":"BELLMANN R","year":"2017","journal-title":"Infection"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/myc.12747","article-title":"A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species","volume":"61","author":"BONGOMIN F","year":"2018","journal-title":"Mycoses"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mmcr.2019.04.004","article-title":"Cryptococcosis due to Cryptococcus gattii VGII in southeast Brazil: The One Health approach revealing a possible role for domestic cats","volume":"24","author":"BRITO-SANTOS F","year":"2019","journal-title":"Med Mycol Case Rep"},{"key":"ref10","first-page":"245","article-title":"Prevalencia y susceptibilidad de Cryptococcus neoformans aislados del suelo y excretas de palomas en la ciudad de Macei\u00f3 - Al, Brasil","volume":"20","author":"CALUMBY RJN","year":"2021","journal-title":"Rev Ci\u00ean M\u00e9d Biol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1473-3099(23)00731-4","article-title":"Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM","volume":"24","author":"CHANG CC","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/13693786.2012.715763","article-title":"Fluconazole resistance in cryptococcal disease: Emerging or intrinsic?","volume":"51","author":"CHEONG JWS","year":"2013","journal-title":"Med Mycol"},{"key":"ref13","series-title":"Relat\u00f3rio de Recomenda\u00e7\u00e3o No 614","year":"2021"},{"key":"ref14","first-page":"1","article-title":"Cryptococcosis\u2014a systematic review to inform the World Health Organization Fungal Priority Pathogens List","volume":"62","author":"DAO A","year":"2024","journal-title":"Med Mycol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jof7110909","article-title":"Molecular mechanisms of 5-fluorocytosine resistance in yeasts and filamentous fungi","volume":"7","author":"DELMA FZ","year":"2021","journal-title":"J Fungi"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fvets.2018.00014","article-title":"The one health concept: 10 years old and a long road ahead","volume":"5","author":"DESTOUMIEUX-GARZ\u00d3N D","year":"2018","journal-title":"Front Vet Sci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pathogens12050662","article-title":"Exposure of Cryptococcus neoformans to Seven Commonly Used Agricultural Azole Fungicides Induces Resistance to Fluconazole as Well as Cross-Resistance to Voriconazole, Posaconazole, Itraconazole and Isavuconazole","volume":"12","author":"DRAKULOVSKI P","year":"2023","journal-title":"Pathogens"},{"key":"ref18","first-page":"1","article-title":"Development of nose-to-brain delivery of ketoconazole by nanostructured lipid carriers against cryptococcal meningoencephalitis in mice","volume":"183","author":"DU W","year":"2019","journal-title":"Colloid Surface B"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jof8030309","article-title":"Commercial Methods for Antifungal Susceptibility Testing of Yeasts: Strengths and Limitations as Predictors of Resistance","volume":"8","author":"ESPINEL-INGROFF A","year":"2022","journal-title":"J Fungi"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jof9050542","article-title":"Methods for Antifungal Susceptibility Testing of the Cryptococcus neoformans\/C gattii Complex: Strengths and Limitations","volume":"9","author":"ESPINEL-INGROFF A","year":"2023","journal-title":"J Fungi"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jof7010024","article-title":"Antifungal resistance among less prevalent Candida non-albicans and other yeasts versus established and under development agents: A literature review","volume":"7","author":"ESPINEL-INGROFF A","year":"2021","journal-title":"J Fungi"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1128\/AAC.06252-11","article-title":"Cryptococcus neoformans-Cryptococcus gattii species complex: An international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine","volume":"56","author":"ESPINEL-INGROFF A","year":"2012","journal-title":"Antimicrob Agents Ch"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1128\/AAC.01115-12","article-title":"Cryptococcus neoformans-Cryptococcus gattii species complex: An international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole","volume":"56","author":"ESPINEL-INGROFF A","year":"2012","journal-title":"Antimicrob Agents Ch"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12281-020-00378-3","article-title":"Should Etest MICs for Yeasts Be Categorized by Reference (BPs\/ECVs) or by Etest (ECVs) Cutoffs as Determinants of Emerging Resistance?","volume":"14","author":"ESPINEL-INGROFF A","year":"2020","journal-title":"Curr Fungal Infect Rep"},{"key":"ref25","first-page":"1","article-title":"Antifungal susceptibility testing and genotyping characterization of Cryptococcus neoformans and gattii isolates from HIV-infected patients of Ribeir\u00e3o Preto, S\u00e3o Paulo, Brazil","volume":"58","author":"FIGUEIREDO TP","year":"2016","journal-title":"Rev Inst Med Trop SP"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jof7040282","article-title":"Cryptococcus neoformans and Cryptococcus gattii species complexes in Latin America: A map of molecular types, genotypic diversity, and antifungal susceptibility as reported by the Latin American cryptococcal study group","volume":"7","author":"FIRACATIVE C","year":"2021","journal-title":"J Fungi"},{"key":"ref27","article-title":"Recent advances in Cryptococcus and cryptococcosis","volume":"10","author":"FIRACATIVE C","year":"2022","journal-title":"Microorganisms"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s42770-024-01313-1","article-title":"Molecular characterization of clinical and environmental isolates from the Cryptococcus neoformans\/C gattii species complexes of Macei\u00f3, Alagoas, Brazil","volume":"55","author":"FONSECA DLH","year":"2024","journal-title":"Braz J Microbiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.fgb.2015.02.009","article-title":"Recognition of seven species in the Cryptococcus gattii\/Cryptococcus neoformans species complex","volume":"78","author":"HAGEN F","year":"2015","journal-title":"Fungal Genet Biol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mSphere.00238-17","article-title":"Importance of Resolving Fungal Nomenclature: the Case of Multiple Pathogenic Species in the Cryptococcus Genus","volume":"2","author":"HAGEN F","year":"2017","journal-title":"mSphere"},{"key":"ref31","first-page":"1","article-title":"Pulmonary Cryptococcosis","volume":"8","author":"HOWARD-JONES AR","year":"2022","journal-title":"J Fungi"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJMoa2111904","article-title":"Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis","volume":"386","author":"JARVIS JN","year":"2022","journal-title":"New Engl J Med"},{"key":"ref33","first-page":"1","article-title":"Minimum inhibitory concentrations of antifungals against invasive isolates of Cryptococcus species worldwide: Global antifungal antimicrobial testing leadership and surveillance program, 2010\u20132020","volume":"63","author":"JEAN SS","year":"2024","journal-title":"Int J Antimicrob Ag"},{"key":"ref34","article-title":"CRYPTOCOCCOSIS: A bibliographic narrative review on antifungal resistance","volume":"95","author":"KAKIZAKI MIT","year":"2023","journal-title":"An Acad Bras Cienc"},{"key":"ref35","first-page":"1","article-title":"The Case for Adopting the \u201cSpecies Complex\u201d Nomenclature for the Etiologic Agents of Cryptococcosis","volume":"2","author":"KWON-CHUNG KJ","year":"2017","journal-title":"mSphere"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev.micro.60.080805.142102","article-title":"The Biology of the Cryptococcus neoformans Species Complex","volume":"60","author":"LIN X","year":"2006","journal-title":"Annu Rev Microbiol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/cid\/cir745","article-title":"Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis","volume":"54","author":"LOYSE A","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1473-3099(18)30493-6","article-title":"Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries","volume":"19","author":"LOYSE A","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"ref39","first-page":"1","article-title":"Disseminated and cutaneous cryptococcosis by C neoformans VNI in an immunocompetent patient","volume":"56","author":"MARANH\u00c3O FCA","year":"2020","journal-title":"J Bras Patol Med Lab"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrmicro.2015.6","article-title":"Cryptococcus: From environmental saprophyte to global pathogen","volume":"14","author":"MAY RC","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.idc.2015.10.006","article-title":"Cryptococcosis","volume":"30","author":"MAZIARZ EK","year":"2016","journal-title":"Infect Dis Clin N Am"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/13693780902953886","article-title":"Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii","volume":"47","author":"MEYER W","year":"2009","journal-title":"Med Mycol"},{"key":"ref43","first-page":"1","article-title":"Antifungal Resistance in Cryptococcal Infections","volume":"13","author":"MELHEM MSC","year":"2024","journal-title":"Pathogens"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mmcr.2017.11.004","article-title":"Emerging fluconazole resistance: Implications for the management of cryptococcal meningitis","volume":"19","author":"MPOZA E","year":"2018","journal-title":"Med Mycol Case Rep"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s40265-022-01757-5","article-title":"Treatment of Cryptococcal Meningitis: How Have We Got Here and Where are We Going?","volume":"82","author":"NGAN NTT","year":"2022","journal-title":"Drugs"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/cid\/ciaa1544","article-title":"Antifungal Susceptibility Does Not Correlate with Fungal Clearance or Survival in AIDS-Associated Cryptococcal Meningitis","volume":"73","author":"CONNOR L","year":"2021","journal-title":"Clin Infect Dis"},{"key":"ref47","first-page":"1","article-title":"Resistance of Asian Cryptococcus neoformans serotype a is confined to few microsatellite genotypes","volume":"7","author":"PAN W","year":"2012","journal-title":"PLoS ONE"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/S1473-3099(22)00499-6","article-title":"The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis","volume":"2020","author":"RAJASINGHAM R","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"RAJASINGHAM R","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1128\/AAC.00295-09","article-title":"Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence","volume":"53","author":"SIONOV E","year":"2009","journal-title":"Antimicrob Agents Ch"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/microorganisms8040613","article-title":"New approaches for cryptococcosis treatment","volume":"8","author":"SPADARI CC","year":"2020","journal-title":"Microorganisms"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/hiv.13412","article-title":"An updated systematic review of HIV-associated cryptococcal meningitis treatment strategies","volume":"24","author":"SHAPIRO AE","year":"2023","journal-title":"HIV Med"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/clinids\/12.Supplement_3.S276","article-title":"Fluconazole and other azoles: Translation of in vitro activity to in vivo and clinical efficacy","volume":"12","author":"TROKE PF","year":"1990","journal-title":"Rev Infect Dis"},{"key":"ref54","series-title":"Fungal Priority Pathogens List to Guide Research, Development and Public Health Action","year":"2022"},{"key":"ref55","series-title":"Guidelines for Diagnosing, Preventing and Managing Cryptococcal Disease among Adults, Adolescents and Children Living with HIV","year":"2022"}],"container-title":["Anais da Academia Brasileira de Ci\u00eancias"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0001-37652026000203801&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T20:00:42Z","timestamp":1779480042000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0001-37652026000203801&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026]]}},"alternative-id":["S0001-37652026000203801"],"URL":"https:\/\/doi.org\/10.1590\/0001-3765202620251002","relation":{},"ISSN":["1678-2690","0001-3765"],"issn-type":[{"value":"1678-2690","type":"electronic"},{"value":"0001-3765","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e20251002"}}